Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

by Berhe, Mezgebe , Wang, Hui , Richmond, Gary J. , Molina, Jean-Michel , Margot, Nicolas A. , Castagna, Antonella , Baeten, Jared M. , Siripassorn, Krittaecho , DeJesus, Edwin , Ruane, Peter J. , Hyland, Robert H. , Sinclair, Gary I. , Dvory-Sobol, Hadas , Rhee, Martin S. , Brainard, Diana M. , Stellbrink, Hans-Jurgen , Segal-Maurer, Sorana

in AIDS / Anti-HIV Agents - therapeutic use / Antiviral activity / Antiviral drugs / Capsid / CD4 antigen / CD4 Lymphocyte Count / Design / Drug dosages / Drug resistance / Drug Therapy, Combination / Enrollments / Global Health / HIV / HIV Infections - drug therapy / HIV-1 - genetics / Human immunodeficiency virus / Humans / Immune system / Infections / Infectious Disease / Multidrug resistance / Multidrug resistant organisms / Patients / Placebos / RNA, Viral / Viral Load

2022

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

2022

Confirm

Do you wish to request the book?

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

2022

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

Berhe, Mezgebe,

Wang, Hui,

Richmond, Gary J.,

Molina, Jean-Michel,

Margot, Nicolas A.,

Castagna, Antonella,

Baeten, Jared M.,

Siripassorn, Krittaecho,

DeJesus, Edwin,

Ruane, Peter J.,

Hyland, Robert H.,

Sinclair, Gary I.,

Dvory-Sobol, Hadas,

Rhee, Martin S.,

Brainard, Diana M.,

Stellbrink, Hans-Jurgen,

Segal-Maurer, Sorana

2022

Overview

Lenacapavir is a first-in-class capsid inhibitor for the treatment of multidrug-resistant HIV-1 infection. In this initial trial, patients who received lenacapavir had a greater reduction from baseline in viral load than those who received placebo.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

AIDS

/ Anti-HIV Agents - therapeutic use

/ Antiviral activity

/ Antiviral drugs

/ Capsid

/ CD4 antigen

/ CD4 Lymphocyte Count